Coverage of our peer-reviewed research and news reporting in the healthcare and mainstream press.
A study published in The American Journal of Accountable Care®, a sister journal of The American Journal of Managed Care® (AJMC®), was highlighted in an article from Health Payer Intelligence. The study, “Creating Successful Alternative Payment Models,” drew on the experience of past and present payment reforms to suggest principles for successfully designing alternative payment models.
America’s Health Insurance Plans’ Wednesday Accountable Care SmartBrief mentioned the AJMC® article, “Oregon Approves Policies to Continue Value-Based Care Push in Medicaid,” which reported on Oregon’s approval of new policies focused on behavioral health, value, and social determinants of health in the state’s coordinated care organizations.
Citizen Tribune covered AJMC®’s announcement of Rose Gerber, director of patient advocacy and education for the Community Oncology Alliance, being the moderator for the “Advancing Care Management” panel at the upcoming 2018 Patient Centered Oncology Care® meeting being held at the Sofitel Philadelphia Hotel on November 16.
Navigating Sport-Related Neurospine Injuries, Surgery, and Managed Care
February 25th 2025On this episode of Managed Care Cast, we speak with Arthur L. Jenkins III, MD, FACS, CEO of Jenkins NeuroSpine, to explore the intersection of advanced surgical care for sport-related neurospine injuries and managed care systems.
Listen
Use of AI Lets Health System Find Lung Cancer at Early Stages
March 8th 2025Artificial intelligence (AI) helps a Sarasota, Florida, health system catch lung nodules that appear on CT scans for patients treated for scores of conditions, allowing them to be referred for a possible lung cancer diagnosis.
Read More
Varied Access: The Pharmacogenetic Testing Coverage Divide
February 18th 2025On this episode of Managed Care Cast, we speak with the author of a study published in the February 2025 issue of The American Journal of Managed Care® to uncover significant differences in coverage decisions for pharmacogenetic tests across major US health insurers.
Listen